Hatem Elalfy
7PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 16, 2021
Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19.Hatem Elalfy, Tarek Besheer, Ahmed El-Mesery
|Sep 16, 2020
Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patients.Khaled Farid, Hatem Elalfy, Salwa M Abo El-Khair
|Oct 17, 2019
Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients.Mustafa Neamatallah, Mahmoud El-Bendary, Hatem Elalfy
|Sep 04, 2018
Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection.M El-Bendary, M Neamatallah, H Elalfy
|Jul 12, 2018
Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization.H Elalfy, T Besheer, M A El-Maksoud
|Jun 28, 2018
The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection.M El-Bendary, M Neamatallah, H Elalfy
Pageof 2
